Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients.

Direct admission Emergency department Hematological malignancy Intensive care unit

Journal

Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873

Informations de publication

Date de publication:
02 Oct 2019
Historique:
received: 25 04 2019
accepted: 21 09 2019
entrez: 4 10 2019
pubmed: 4 10 2019
medline: 4 10 2019
Statut: epublish

Résumé

The aim of this study was to assess the benefit of direct ICU admission from the emergency department (ED) compared to admission from wards, in patients with hematological malignancies requiring critical care. Post hoc analysis derived from a prospective, multicenter cohort study of 1011 critically ill adult patients with hematologic malignancies admitted to 17 ICU in Belgium and France from January 2010 to May 2011. The variable of interest was a direct ICU admission from the ED and the outcome was in-hospital mortality. The association between the variable of interest and the outcome was assessed by multivariable logistic regression after multiple imputation of missing data. Several sensitivity analyses were performed: complete case analysis, propensity score matching and multivariable Cox proportional-hazards analysis of 90-day survival. Direct ICU admission from the ED occurred in 266 (26.4%) cases, 84 of whom (31.6%) died in the hospital versus 311/742 (41.9%) in those who did not. After adjustment, direct ICU admission from the ED was associated with a decreased in-hospital mortality (adjusted OR: 0.63; 95% CI 0.45-0.88). This was confirmed in the complete cases analysis (adjusted OR: 0.64; 95% CI 0.45-0.92) as well as in terms of hazard of death within the 90 days after admission (adjusted HR: 0.77; 95% CI 0.60-0.99). By contrast, in the propensity score-matched sample of 402 patients, direct admission was not associated with in-hospital mortality (adjusted OR: 0.92; 95% CI 0.84-1.01). In this study, patients with hematological malignancies admitted to the ICU were more likely to be alive at hospital discharge if they were directly admitted from the ED rather than from the wards. Assessment of early predictors of poor outcome in cancer patients admitted to the ED is crucial so as to allow early referral to the ICU and avoid delays in treatment initiation and mis-orientation.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to assess the benefit of direct ICU admission from the emergency department (ED) compared to admission from wards, in patients with hematological malignancies requiring critical care.
METHODS METHODS
Post hoc analysis derived from a prospective, multicenter cohort study of 1011 critically ill adult patients with hematologic malignancies admitted to 17 ICU in Belgium and France from January 2010 to May 2011. The variable of interest was a direct ICU admission from the ED and the outcome was in-hospital mortality. The association between the variable of interest and the outcome was assessed by multivariable logistic regression after multiple imputation of missing data. Several sensitivity analyses were performed: complete case analysis, propensity score matching and multivariable Cox proportional-hazards analysis of 90-day survival.
RESULTS RESULTS
Direct ICU admission from the ED occurred in 266 (26.4%) cases, 84 of whom (31.6%) died in the hospital versus 311/742 (41.9%) in those who did not. After adjustment, direct ICU admission from the ED was associated with a decreased in-hospital mortality (adjusted OR: 0.63; 95% CI 0.45-0.88). This was confirmed in the complete cases analysis (adjusted OR: 0.64; 95% CI 0.45-0.92) as well as in terms of hazard of death within the 90 days after admission (adjusted HR: 0.77; 95% CI 0.60-0.99). By contrast, in the propensity score-matched sample of 402 patients, direct admission was not associated with in-hospital mortality (adjusted OR: 0.92; 95% CI 0.84-1.01).
CONCLUSIONS CONCLUSIONS
In this study, patients with hematological malignancies admitted to the ICU were more likely to be alive at hospital discharge if they were directly admitted from the ED rather than from the wards. Assessment of early predictors of poor outcome in cancer patients admitted to the ED is crucial so as to allow early referral to the ICU and avoid delays in treatment initiation and mis-orientation.

Identifiants

pubmed: 31578641
doi: 10.1186/s13613-019-0587-7
pii: 10.1186/s13613-019-0587-7
pmc: PMC6775178
doi:

Types de publication

Journal Article

Langues

eng

Pagination

110

Références

Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Blood Rev. 2015 Nov;29(6):359-67
pubmed: 25998991
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Intensive Care Med. 2015 Feb;41(2):348-50
pubmed: 25578679
Stat Med. 2014 May 10;33(10):1685-99
pubmed: 24323618
J Clin Oncol. 2013 Aug 1;31(22):2810-8
pubmed: 23752112
Stat Med. 2014 Mar 15;33(6):1057-69
pubmed: 24123228
J Crit Care. 2011 Aug;26(4):373-8
pubmed: 21036527
Crit Care. 2013 Apr 19;17(2):R76
pubmed: 23601765
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Leuk Lymphoma. 2013 Aug;54(8):1724-9
pubmed: 23185988
Acad Emerg Med. 2012 Mar;19(3):294-303
pubmed: 22435862
PLoS One. 2017 Jul 27;12(7):e0181808
pubmed: 28749989
J Clin Oncol. 2005 Jul 1;23(19):4406-13
pubmed: 15994150
Crit Care. 2011;15(1):R28
pubmed: 21244671
Crit Care Med. 2015 Jul;43(7):1439-48
pubmed: 25803653
J Crit Care. 2015 Feb;30(1):78-84
pubmed: 25128441
Intensive Care Med. 2004 Apr;30(4):580-8
pubmed: 14997295
Intensive Care Med. 2012 Sep;38(9):1505-13
pubmed: 22592633
Am J Respir Crit Care Med. 2012 May 15;185(10):1081-7
pubmed: 22345582
Lancet. 2010 May 15;375(9727):1695-703
pubmed: 20472172
Crit Care Med. 2007 Jun;35(6):1477-83
pubmed: 17440421

Auteurs

Olivier Peyrony (O)

Emergency Department, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75010, Paris, France. o.peyrony@hotmail.fr.

Sylvie Chevret (S)

Biostatistics and Medical Information Department, Hôpital Saint-Louis, Paris, France.
Centre de Recherche en Épidémiologie et Statistiques - Université de Paris (CRESS-INSERM-UMR1153), Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments (ECSTRRA) Team, Paris, France.
Université de Paris, Paris, France.

Anne-Pascale Meert (AP)

Intensive Care Unit, Institut Jules Bordet, Université libre de Bruxelles (ULB), Brussels, Belgium.

Pierre Perez (P)

Intensive Care Unit, Hôpital Brabois, Vandoeuvre Les Nancy, France.

Achille Kouatchet (A)

Intensive Care Unit, Centre hospitalier régional universitaire, Angers, France.

Frédéric Pène (F)

Université de Paris, Paris, France.
Intensive Care Unit, Hôpital Cochin, Paris, France.
Institut Cochin, INSERM U1016, CNRS UMR 8104, Paris, France.

Djamel Mokart (D)

Intensive Care Unit, Institut Paoli Calmettes, Marseille, France.

Virginie Lemiale (V)

Intensive Care Unit, Hôpital Saint-Louis, Paris, France.

Alexandre Demoule (A)

Intensive Care Unit, Hôpital Pitié-Salpêtrière, Paris, France.
INSERM, UMRS 1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France.
Université Paris Sorbonne, Paris, France.

Martine Nyunga (M)

Intensive Care Unit, Hôpital Victor Provo, Roubaix, France.

Fabrice Bruneel (F)

Intensive Care Unit, Hôpital André Mignot, Versailles, France.

Christine Lebert (C)

Intensive Care Unit, Centre hospitalier départemental Vendee, La Roche Sur Yon, France.

Dominique Benoit (D)

Intensive Care Unit, Hôpital universitaire de Ghent, Ghent, Belgium.

Adrien Mirouse (A)

Intensive Care Unit, Hôpital Saint-Louis, Paris, France.

Elie Azoulay (E)

Centre de Recherche en Épidémiologie et Statistiques - Université de Paris (CRESS-INSERM-UMR1153), Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments (ECSTRRA) Team, Paris, France.
Université de Paris, Paris, France.
Intensive Care Unit, Hôpital Saint-Louis, Paris, France.

Classifications MeSH